[Federal Register Volume 75, Number 77 (Thursday, April 22, 2010)]
[Notices]
[Pages 21002-21003]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-9312]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Drug Discovery, Chemoprevention and Targeted Therapy.
    Date: May 25-27, 2010.
    Time: 8 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Peter J. Wirth, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8129, 
Bethesda, MD 20892-8328. 301-496-7565.[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Innovative and Early Stage Development of Emerging 
Technologies in Biospecimen Science.
    Date: June 14, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 21003]]

    Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 
8120 Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Donald L. Coppock, PhD, Scientific Review 
Officer, Special Review and Logistic Branch, Division of Extramural 
Activities, NCI, National Institutes of Health, 6116 Executive 
Blvd., Rm 7151, Bethesda, MD 20892. 301-451-9385. 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, SPORE in Lymphoma and Breast Cancer.
    Date: June 15-16, 2010.
    Time: 5 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Shamala K. Srinivas, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 8123, Bethesda, MD 20892. 301-594-1224. [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: April 16, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-9312 Filed 4-21-10; 8:45 am]
BILLING CODE 4140-01-P